Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Internal Medicine
|
June 20, 2014
Taming the cancer cell
H Jernberg Wiklund, B Westermark
European Journal of Haematology
|
April 1, 1991
Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro
H Jernberg-Wiklund, M Pettersson, K Nilsson
Leukemia
|
April 1, 1992
Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop
H Jernberg-Wiklund, M Pettersson, M Carlsson, et al.
Current Topics in Microbiology and Immunology
|
July 9, 1999
The control of proliferation, survival and apoptosis in human multiple myeloma cells in vitro
K Nilsson, P Georgii-Hemming, H Spets, et al.
British Journal of Haematology
|
July 1, 1997
The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines
H Spets, H Jernberg-Wiklund, C Sambade, et al.
International Journal of Cancer
|
April 22, 1992
Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line
H Jernberg-Wiklund, M Pettersson, L G Larsson, et al.
Blood
|
October 9, 1998
Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines
H Spets, P Georgii-Hemming, J Siljason, et al.
Blood
|
January 15, 1992
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
M Pettersson, H Jernberg-Wiklund, L G Larsson, et al.
Leukemia
|
February 1, 2012
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model
E Van Valckenborgh, W Matsui, P Agarwal, et al.
Cancer Gene Therapy
|
June 22, 2013
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy
H Karlsson, S C H Karlsson, A C Lindqvist, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Internal Medicine
|
June 20, 2014
Taming the cancer cell
H Jernberg Wiklund, B Westermark
European Journal of Haematology
|
April 1, 1991
Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro
H Jernberg-Wiklund, M Pettersson, K Nilsson
Leukemia
|
April 1, 1992
Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop
H Jernberg-Wiklund, M Pettersson, M Carlsson, et al.
Current Topics in Microbiology and Immunology
|
July 9, 1999
The control of proliferation, survival and apoptosis in human multiple myeloma cells in vitro
K Nilsson, P Georgii-Hemming, H Spets, et al.
British Journal of Haematology
|
July 1, 1997
The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines
H Spets, H Jernberg-Wiklund, C Sambade, et al.
International Journal of Cancer
|
April 22, 1992
Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line
H Jernberg-Wiklund, M Pettersson, L G Larsson, et al.
Blood
|
October 9, 1998
Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines
H Spets, P Georgii-Hemming, J Siljason, et al.
Blood
|
January 15, 1992
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
M Pettersson, H Jernberg-Wiklund, L G Larsson, et al.
Leukemia
|
February 1, 2012
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model
E Van Valckenborgh, W Matsui, P Agarwal, et al.
Cancer Gene Therapy
|
June 22, 2013
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy
H Karlsson, S C H Karlsson, A C Lindqvist, et al.
Page
of 2